- Business Type:
- Manufacturer, Trading Company
- Year Established:
- 1998
- Total Revenue:
- US$10 Million - US$50 Million
- Main Markets:
- North America, South America, Eastern Europe, Southeast Asia, Africa, Mid East, Eastern Asia, Western Europe
Company Description
BBCA Pharmaceuticals is constituted of three systems which are pharmaceutical R&D, production, and sale. It has five pharmaceutical plants and 42 GMP certified production line, mainly involving R&D, production and sale of biological pharmacy, chemical pharmacy, and traditional Chinese medicine and possessing six classes of products including antipyretic-analgesic drug, antibiotic, anti-tumor drug, preparation of traditional Chinese medicine, cardiovascular drug, and nervous system drug. BBCA Pharmaceuticals can produce 11 formulations including large-volume injection, small-volume injection, powder injection, capsules, powders, tablets, granules, films, eye drops, patches, etc, 395 varieties, as well as many kinds of material drugs.